Proliferative potential after DNA damage and non-homologous end joining are affected by loss of securin

Cell Death and Differentiation

Volumn 15, Issue 1, 2008, Pages 202-212

  Bernal, J A ^a,b   Roche, M ^b   Mendez Vidal C ^a   Espina, A ^a   Tortolero, M ^c   Pintor Toro, J A ^a  

^a CABIMER Andalusian Center for Molecular Biology and Regenerative Medicine CSIC University of Seville UPO   (Spain)

^b MRC/Hutchinson Cell Cancer Unit   (United Kingdom)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; NON HOMOLOGOUS DNA END JOINING PROTEIN; SECURIN; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL STRESS; CELL SURVIVAL; CHROMATID ABERRATION; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DNA DAMAGE; GENOMIC INSTABILITY; GENOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; REGULATORY MECHANISM;

BASE SEQUENCE; CAMPTOTHECIN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME ABERRATIONS; DNA; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; DNA REPAIR; DOXORUBICIN; GENOMIC INSTABILITY; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; RNA, SMALL INTERFERING;

EID: 37349116092     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402254     Document Type: Article

References (32)

1. Dominguez A, Ramos-Morales F, Romero F, Rios RM, Dreyfus F, Tortolero M et al. hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG. Oncogene 1998; 17: 2187-2193.
2. Zhang X, Horwitz GA, Prezant TR, Valentini A, Nakashima M, Bronstein MD et al. Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol. Endocrinol 1999; 13: 156-166.
3. Saez C, Japon MA, Ramos-Morales F, Romero F, Segura DI, Tortolero M et al. hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene 1999; 18: 5473-5476.
4. Heaney AP, Singson R, McCabe CJ, Nelson V, Nakashima M, Melmed S. Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 2000; 355: 716-719.
5. Saez C, Martinez-Brocca MA, Castilla C, Soto A, Navarro E, Tortolero M et al. Prognostic significance of human pituitary tumor-transforming gene immunohistochemical expression in differentiated thyroid cancer. The J Clin Endocrinol Metab 2006; 91: 1404-1409.
6. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003; 33: 49-54.
7. Bernal JA, Luna R, Espina A, Lazaro I, Ramos-Morales F, Romero F et al. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat Genet 2002; 32: 306-311.
8. Difilippantonio MJ, Zhu J, Chen HT, Meffre E, Nussenzweig MC, Max EE et al. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 2000; 404: 510-514.
9. Ferguson DO, Sekiguchi JM, Chang S, Frank KM, Gao Y, DePinho RA et al. The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc Natl Acad Sci USA 2000; 97: 6630-6633.
10. Gu Y, Seidl KJ, Rathbun GA, Zhu C, Manis JP, van der Stoep N et al. Growth retardation and leaky SCID phenotype of Ku70-deficient mica. Immunity 1997: 7: 653-665.
11. Gao Y, Sun Y, Frank KM, Dikkes P, Fujiwara Y, Seidl KJ et al. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 1998; 95: 891-902.
12. Romero F, Multon MC, Ramos-Morales F, Dominguez A, Bernal JA, Pintor-Toro JA et al. Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit ot the DNA-dependent protein kinase. Nucleic Acids Res 2001; 29: 1300-1307.
13. Jallepalli PV, Waizenegger IC, Bunz F, Langer S, Speicher MR, Peters JM et al. Securin is required for chromosomal stability in human cells. Cell 2601; 105 445-457.
14. Pfleghaar K, Heubes S, Cox J, Stemmann O, Speicher MR. Securin is not required for chromosomal stability in human cells. PLoS Biol 2005; 3: E416.
15. Phillips JW, Morgan WF. Illegitimate recombination induced by DNA double-strand breaks in a mammalian chromosome. Mol Cell Biol 1994; 14: 5794-5803.
16. Liang F, Jasin M. Ku80-deficient cells exhibit excess degradation of extrachromosomal DNA. J Biol Chem 1996; 271: 14405-14411.
17. Kim DS, Franklyn JA, Smith VE, Stratford AL, Pemberton HN, Warfield, A et al. Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity. Carcinogenesis 2007; 28: 749-759.
18. Jallepalli PV, Waizenegger IC, Bunz F, Langer S, Speicher MR, Peters JM et al. Securin is required for chromosomal stability in human cells. Cell 2001; 105: 445-457.
19. Mei J, Huang X, Zhang P. Securin is not required for cellular viability, but is required for normal growth of mouse embryonic fibroblasts. Curr Biol 2001, 11: 1197-1201.
20. Arnaudeau C, Lundin C, Helleday T. DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells. J Mol Biol 2001; 307: 1235-1245.
21. Adachi N, So S, Koyama H. Loss of nonhomologous end joining confers camptothecin resistance in DT40 cells. Implications for the repair of topoisomerase I-mediated DNA damage. J Biol Chem 2004; 279: 37343-37348.
22. Ninomiya Y, Suzuki K, Ishii C, Inoue H. Highly efficient gene replacements in Neurospora strains deficient for nonhomologous end-joining. Proc Natl Acad Sci USA 2004; 101: 12248-12253.
23. Milne GT, Jin S, Shannon KB, Weaver DT. Mutations in two Ku homologs define a DNA end-joining repair pathway in Saccharomyces cerevisiae. Mol Cell Biol 1996; 16: 4189-4198.
24. Ayene IS, Ford LP, Koch CJ. Ku protein targeting by Ku70 small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and gamma radiation. Mol Cancer Ther 2005; 4: 529-536.
25. Gallego ME, Bleuyard JY, Daoudal-Cotterell S, Jallut N, White CI. Ku80 plays a role in non-homologous recombination but is not required for T-DNA integration in Arabidopsis. Plant J 2003; 35: 557-565.
26. Pourquier P, Pommier Y. Topoisomerase I-mediated DNA damage. Adv Cancer Res 2001; 80: 189-216.
27. Furuta T, Takemura H, Liao ZY, Aune GJ, Radon C, Sedelnikova OA et al. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage,complaxes. J Biol Chem 2003; 278: 20303-20312.
28. Vance JR, Wilson TE. Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damage. Proc Natl Acad Sci USA 2002; 99: 13669-13674.
29. Nitiss J, Wang JC. DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc Natl Acad Sci USA 1988; 85: 7501-7505.
30. Foray N, Priestley A, Alsbeih G, Badie C, Capulas EP, Arlett CF et al. Hypersensitivity of ataxia telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks. Int J Radiat Biol 1997; 72: 271-283.
31. Lundberg R, Mavinakere M, Campbell C. Deficient DNA end joining activity in extracts from fanconi anemia fibroblasts. J Biol Chem 2001; 276: 9543-9549.
32. Thalhammer S, Koehler U, Stark RW, Heckl WM. GTG banding pattern on human metaphase chromosomes revealed by high resolution atomic-force microscopy. J Microsc 2001; 202 (Part 3): 464-467.